Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought
FotoshopTofs / Pixabay

Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought

According to a story from Fierce Biotech, recent research is highlighting the possibility that PARP inhibitors, a type of targeted therapy that it mostly used to treat breast cancer and…

Continue Reading Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought

Researchers are Investigating the Effects of Endocannabinoids on Osteosarcoma

Researchers from the University of Illinois have been studying the effects of endocannabinoids (a type of molecule that occurs naturally in the body) on cancer. So far, the researchers have…

Continue Reading Researchers are Investigating the Effects of Endocannabinoids on Osteosarcoma
Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment
PixelAnarchy / Pixabay

Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment

According to a story from news.com.au, patients in Western Australia will start getting much cheaper access to a highly valuable treatment next month for a rare form of cancer called…

Continue Reading Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment
The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer
Source: Pixabay.com

The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer

A drug to treat prostate cancer has been approved by the US Food and Drug Administration. The drug, Xtandi ® (enzalutamide), had previously been approved for castration-resistant prostate cancer (CRPC)…

Continue Reading The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer
Close Menu